CN110684003A - A simple and efficient total synthesis method of icariin and its derivatives - Google Patents

A simple and efficient total synthesis method of icariin and its derivatives Download PDF

Info

Publication number
CN110684003A
CN110684003A CN201910939978.7A CN201910939978A CN110684003A CN 110684003 A CN110684003 A CN 110684003A CN 201910939978 A CN201910939978 A CN 201910939978A CN 110684003 A CN110684003 A CN 110684003A
Authority
CN
China
Prior art keywords
group
isopentenyl
synthesis method
compound
total synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910939978.7A
Other languages
Chinese (zh)
Inventor
张国林
王淳
熊伟
张继超
万顺莉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu Institute of Biology of CAS
Original Assignee
Chengdu Institute of Biology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Institute of Biology of CAS filed Critical Chengdu Institute of Biology of CAS
Priority to CN201910939978.7A priority Critical patent/CN110684003A/en
Publication of CN110684003A publication Critical patent/CN110684003A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明属于天然药物合成领域,具体涉及一种淫羊藿素及其衍生物的全合成方法。具体技术方案为:以2ˊ‑羟基苯乙酮和苯甲醛为原料,先在有机多元酸金属离子配合物的催化下,在原料的芳香环上引入异戊烯基,再在温和、绿色的条件下构建黄酮醇骨架,进而合成包括淫羊藿素及其衍生物在内的异戊烯基黄酮类化合物。该方法有效克服了先构建黄酮、后引入异戊烯基时底物溶解性差、区域选择性差等局限性,避免了常规异戊烯基化方法中需要频繁引入和脱除保护基团的问题,极大简化了合成路线;同时避免了异戊烯基重排法中产物复杂、副产物多的问题。本发明提供的全合成方法条件温和、操作简便、总体收率高,适合进行异戊烯基黄酮类化合物的规模化生产。The invention belongs to the field of natural medicine synthesis, and in particular relates to a total synthesis method of icariin and derivatives thereof. The specific technical scheme is as follows: using 2′-hydroxyacetophenone and benzaldehyde as raw materials, firstly, under the catalysis of organic polybasic acid metal ion complexes, isopentenyl is introduced into the aromatic ring of the raw materials, and then under mild and green conditions The flavonol skeleton was constructed under the following conditions, and then prenyl flavonoids including icariin and its derivatives were synthesized. The method effectively overcomes the limitations of poor substrate solubility and poor regioselectivity when the flavonoids are first constructed and the isopentenyl group is introduced later, and the problem of frequent introduction and removal of protective groups in the conventional prenylation method is avoided. The synthetic route is greatly simplified; meanwhile, the problems of complex products and many by-products in the isopentenyl rearrangement method are avoided. The total synthesis method provided by the invention has mild conditions, simple operation and high overall yield, and is suitable for large-scale production of isopentenyl flavonoids.

Description

一种简便高效的淫羊藿素及其衍生物的全合成方法A simple and efficient total synthesis method of icariin and its derivatives

技术领域technical field

本发明属于天然药物合成领域,具体涉及一种简洁高效的淫羊藿素的全合成方法。The invention belongs to the field of natural medicine synthesis, in particular to a simple and efficient total synthesis method of icariin.

背景技术Background technique

淫羊藿素是淫羊藿苷的苷元,淫羊藿苷是小檗科淫羊藿属植物淫羊藿中的一种黄酮类衍生物。传统中医认为淫羊藿属植物具有降压、补肾壮阳的显著功效,被广泛用于治疗心血管疾病、健忘症、关节炎、乏力、阳痿、不孕等疾病。淫羊藿素的分子结构式如下所示:Icariin is the aglycone of icariin, which is a flavonoid derivative of Epimedium, the genus Epimedium of the Berberaceae family. Traditional Chinese medicine believes that Epimedium has significant effects of lowering blood pressure, invigorating kidney and strengthening yang, and is widely used in the treatment of cardiovascular disease, amnesia, arthritis, fatigue, impotence, infertility and other diseases. The molecular structure of icariin is as follows:

Figure BDA0002222605170000011
Figure BDA0002222605170000011

自1935年淫羊藿苷和去甲淫羊藿苷被提取分离及结构鉴定以后,关于淫羊藿素及其苷类衍生物的药理活性研究取得了较大进展。近年来医药科学研究表明,淫羊藿素在体内外均具有较高的抗肝癌活性,其可能通过抑制鞘氨醇激酶I而抑制肝癌细胞起始细胞的恶性生长(Lu,P.H.etc.Oncotarget,2017,8,22800-22810),淫羊藿素衍生物阿可拉定和氟可拉定已经作为Ⅰ类抗肝癌新药进入临床三期研究(药物临床试验登记号:CTR20170668)。然而,淫羊藿素作为淫羊藿苷的母核,在植物淫羊藿中的含量极低,通常需要先提取分离淫羊藿苷,再通过糖苷酶水解糖苷键而获得相应的苷元。中国专利CN1473938、CN101302548、CN107641621和美国专利US6399579分别报道了酶水解法制备淫羊藿苷元的方法,这些方法获取淫羊藿素操作复杂、成本高昂。利用化学方法直接合成淫羊藿素则是一种简便有效的途径。Since icariin and noricariin were extracted, separated and identified in 1935, great progress has been made in the research on the pharmacological activities of icariin and its glycoside derivatives. In recent years, medical scientific research has shown that icariin has high anti-cancer activity in vitro and in vivo, and it may inhibit the malignant growth of hepatoma cell initiating cells by inhibiting sphingosine kinase I (Lu, P.H.etc.Oncotarget, 2017, 8, 22800-22810), icariin derivatives acoradine and flucoradine have entered Phase III clinical studies as class I new anti-cancer drugs (drug clinical trial registration number: CTR20170668). However, as the parent nucleus of icariin, the content of icariin in the plant Epimedium is extremely low, and it is usually necessary to extract and separate icariin first, and then hydrolyze the glycosidic bond by glycosidase to obtain the corresponding aglycone. Chinese patents CN1473938, CN101302548, CN107641621 and U.S. Patent US6399579 respectively report the methods for preparing icariin by enzymatic hydrolysis, which are complicated and expensive to obtain icariin. Using chemical methods to directly synthesize icariin is a simple and effective way.

淫羊藿素是含异戊烯基的黄酮类化合物,以山奈酚或黄酮衍生物为原料通过异戊烯基的引入获得淫羊藿素的半合成方法,或以间苯三酚衍生物为原料、通过黄酮骨架的构建和异戊烯基的引入获得淫羊藿素的全合成方法是目前化学合成淫羊藿素而使用的两种主要方法。其半合成方法的关键步骤是在黄酮骨架的8位选择性引入异戊烯基。在国内外的研究中,半合成淫羊藿素或与淫羊藿素结构相似的异戊烯基黄酮类化合物的方法已有较多报道,其引入异戊烯基的方式主要有以下几种:Icariin is a flavonoid compound containing an isopentenyl group. It is a semi-synthetic method for obtaining icariin through the introduction of a isopentenyl group by using kaempferol or a flavonoid derivative as a raw material, or using a phloroglucinol derivative as a raw material. The total synthesis method of raw materials, the construction of flavonoid skeleton and the introduction of isopentenyl to obtain icariin are the two main methods currently used for chemical synthesis of icariin. The key step of its semi-synthetic method is the selective introduction of a prenyl group at the 8-position of the flavonoid skeleton. In the research at home and abroad, there have been many reports on the methods of semi-synthesizing icariin or isopentenyl flavonoids similar in structure to icariin, and the methods for introducing isopentenyl groups are mainly as follows: :

(1)与2-甲基-3-丁烯-2-醇的偶联反应,反应式如下:(1) with the coupling reaction of 2-methyl-3-butene-2-ol, the reaction formula is as follows:

Jain,A.C.等(August.J.Chem.1975,28,607-619)以山奈酚为原料,经甲基保护酚羟基获得化合物1′,然后在BF3.Et2O催化下与2-甲基-3-丁烯-2-醇偶联生成8-异戊烯基黄酮衍生物(化合物2′)、6-异戊烯基黄酮衍生物(化合物3′)、6,8-二异戊烯基黄酮衍生物(化合物4′)的混合物,分离化合物(2′)即为淫羊藿素衍生物,该方法的缺点是引入异戊烯基的反应没有区域选择性,操作复杂,产物分离困难。Jain, AC et al. (August. J. Chem. 1975, 28 , 607-619 ) used kaempferol as raw material, protected the phenolic hydroxyl group with methyl to obtain compound 1', and then reacted with 2-methyl- Coupling of 3-buten-2-ol to generate 8-prenyl flavone derivatives (compound 2'), 6-prenyl flavone derivatives (compound 3'), 6,8-diprenyl The mixture of flavonoid derivatives (compound 4'), the isolated compound (2') is the icariin derivative. The disadvantage of this method is that the reaction of introducing the isopentenyl group has no regioselectivity, the operation is complicated, and the product separation is difficult.

(2)与异戊烯基卤的亲核取代反应,反应式如下:(2) with the nucleophilic substitution reaction of isopentenyl halide, the reaction formula is as follows:

Figure BDA0002222605170000022
Figure BDA0002222605170000022

Lu,Z.等(J.Chem.Soc.,Perkin Trans.1993,1,1153-1159)在合成甘草黄酮E时,在强碱KOH的作用下,使黄酮衍生物(化合物5′)与异戊烯基溴反应生成8位和6位的异戊烯基黄酮衍生物,即化合物6′和化合物7′,该方法与Jain,A.C.等的方法相似,其缺点是引入异戊烯基的反应区域选择性较差,淫羊藿素衍生物(化合物6′)的收率较低,仅为12%。(J.Chem.Soc., Perkin Trans. 1993, 1, 1153-1159) in the synthesis of licorice flavonoid E, under the action of strong base KOH, the flavonoid derivative (compound 5') is mixed with isotope Pentenyl bromide reacts to generate isopentenyl flavonoid derivatives at 8 and 6 positions, namely compound 6' and compound 7'. This method is similar to the method of Jain, A.C., etc., but its disadvantage is the reaction of introducing isopentenyl. The regioselectivity was poor, and the yield of icariin derivative (compound 6') was low, only 12%.

(3)异戊烯基参与的重排反应,反应式如下:(3) the rearrangement reaction that isopentenyl participates in, the reaction formula is as follows:

Figure BDA0002222605170000031
Figure BDA0002222605170000031

前期本研究组Mei,Q.G.等(Beilstein J.Org.Chem.2005,11,1220-1225)以山奈酚为原料先合成5-O-异戊烯基黄酮(化合物8′),然后在金属铕配合物Eu(fod)3催化下,发生Claisen-Cope重排反应获得8-位异戊烯基黄酮(化合物9′),该方法的缺点是重排反应产生多个副产物(如化合物10′等),目标物分离操作复杂,催化剂价格昂贵。In the early stage, Mei, QG et al. (Beilstein J.Org.Chem.2005, 11, 1220-1225) used kaempferol as raw material to synthesize 5-O-prenyl flavonoid (compound 8′), and then used metal europium Under the catalysis of the complex Eu(fod) 3 , the Claisen-Cope rearrangement reaction occurs to obtain the 8-position isopentenyl flavonoid (compound 9′). The disadvantage of this method is that the rearrangement reaction produces multiple by-products (such as compound 10′). etc.), the separation operation of the target substance is complicated, and the catalyst is expensive.

以上半合成异戊烯基黄酮类化合物引入异戊烯基的方法普遍存在原料受限、区域选择性差、收率较低等缺点。近年来,发展的镧系金属铕或镱配合物Eu(fod)3作为催化剂应用于异戊烯基的重排反应,虽然在一定程度上提高了反应收率,但仍不能改善反应区域选择性较差的状况,此外,稀土金属价格昂贵,不适合大规模的工业生产。The above methods for semi-synthesizing isopentenyl flavonoids and introducing isopentenyl groups generally have disadvantages such as limited raw materials, poor regioselectivity, and low yields. In recent years, the developed lanthanide metal europium or ytterbium complex Eu(fod) 3 has been used as a catalyst for the rearrangement reaction of isopentenyl groups. Although the reaction yield has been improved to a certain extent, it still cannot improve the reaction regioselectivity. In poorer condition, in addition, rare earth metals are expensive and not suitable for large-scale industrial production.

淫羊藿素全合成的方法报道较少,其合成包括两个关键步骤,一是黄酮骨架的构建,二是异戊烯基的选择性引入。中国专利CN101205223在总结半合成方法的基础上提出了以间苯三酚为原料全合成淫羊藿素的方法,其通过Baker-Venkataraman重排反应构建黄酮醇骨架,再进行Claisen-Cope重排反应引入异戊烯基,10步反应,总收率11%,全合成得到了淫羊藿素,其局限性在于异戊烯基重排反应选择性较差,合成步骤冗长,操作繁琐,成本较高等问题。There are few reports on the total synthesis of icariin, and its synthesis includes two key steps, one is the construction of the flavonoid skeleton, and the other is the selective introduction of the isopentenyl group. Chinese patent CN101205223 proposes a method for the total synthesis of icariin using phloroglucinol as raw material on the basis of summarizing the semi-synthetic method. The flavonol skeleton is constructed by the Baker-Venkataraman rearrangement reaction, and then the Claisen-Cope rearrangement reaction is carried out. Introducing isopentenyl group, 10 steps of reaction, the total yield is 11%, and icariin is obtained by total synthesis. The limitation is that the selectivity of isopentenyl group rearrangement reaction is poor, the synthesis steps are long, the operation is cumbersome, and the cost is relatively high. higher issues.

Figure BDA0002222605170000032
Figure BDA0002222605170000032

与上述方法相似,前期本研究组牟关敏等(Chin.J.Org.Chem.2013,33,1298-1303)以间苯三酚为原料,经HoubenHoesch反应、一锅法Algar-Flynn-Oyamada反应构建黄酮骨架和铕促异戊烯基重排等8步反应实现了淫羊藿素的全合成,总收率4.2%。该方法的缺点在于重排反应引入异戊烯基的步骤反应选择性较差,收率不高。Similar to the above method, the previous research group Mou Guanmin et al. (Chin.J.Org.Chem.2013, 33, 1298-1303) used phloroglucinol as raw material, through HoubenHoesch reaction, one-pot Algar-Flynn-Oyamada reaction to construct Eight-step reactions including flavonoid skeleton and europium-promoted isopentenyl rearrangement achieved the total synthesis of icariin with a total yield of 4.2%. The disadvantage of this method is that the reaction selectivity of the step of introducing the isopentenyl group in the rearrangement reaction is poor, and the yield is not high.

综上所述,目前异戊烯基黄酮类化合物的半合成方法普遍存在反应区域选择性较差、收率偏低的缺点。淫羊藿素的全合成方法虽然已有报道,但现有方法采用的先构建黄酮醇骨架再引入异戊烯基的策略,无法避免因黄酮醇的溶解性较差,在引入异戊烯基的反应中各底物不兼容而导致产率较低的问题,且整体合成路线较长、操作冗繁,成本高昂。此外,该方法采用重排反应引入异戊烯基,仍未解决反应区域选择性较差的问题。因此,提供一种简洁高效的淫羊藿素的全合成新方法具有重要意义。To sum up, the current semi-synthetic methods of prenyl flavonoids generally have the disadvantages of poor reaction regioselectivity and low yield. Although the total synthesis method of icariin has been reported, the strategy of constructing the flavonol skeleton first and then introducing the isopentenyl group in the existing method cannot avoid the poor solubility of the flavonol and the introduction of the isopentenyl group. The incompatibility of each substrate in the reaction leads to the problem of low yield, and the overall synthesis route is long, the operation is tedious, and the cost is high. In addition, this method adopts the rearrangement reaction to introduce the isopentenyl group, which still does not solve the problem of poor reaction regioselectivity. Therefore, it is of great significance to provide a simple and efficient new method for the total synthesis of icariin.

发明内容SUMMARY OF THE INVENTION

本发明的目的是提供一种简便高效的淫羊藿素及其衍生物的全合成新方法。The purpose of the present invention is to provide a simple and efficient new method for the total synthesis of icariin and its derivatives.

为实现上述发明目的,本发明所采用的技术方案是:一种异戊烯基黄酮类化合物的全合成方法,先在有机多元酸金属离子配合物的催化作用下引入异戊烯基,再构建黄酮骨架。In order to achieve the above-mentioned purpose of the invention, the technical scheme adopted in the present invention is: a total synthesis method of isopentenyl flavonoids, firstly introducing isopentenyl under the catalysis of organic polybasic acid metal ion complex, and then constructing Flavonoid Skeleton.

优选的,所述有机多元酸金属离子配合物中,所述有机多元酸为C2~C18的二元脂肪羧酸、C3~C18的三元脂肪羧酸、C4~C18的四元脂肪羧酸、C8~C18的多元芳香羧酸中的一种或多种;所述金属离子选自Mg2+、Al3+、Zn2+、Cu2+、Ba2+、Fe3+、Co2+、Ni2+中的一种或多种。Preferably, in the organic polybasic acid metal ion complex, the organic polybasic acid is a C2-C18 dibasic aliphatic carboxylic acid, a C3-C18 tribasic aliphatic carboxylic acid, a C4-C18 quaternary aliphatic carboxylic acid, One or more of C8-C18 polyvalent aromatic carboxylic acids; the metal ions are selected from Mg 2+ , Al 3+ , Zn 2+ , Cu 2+ , Ba 2+ , Fe 3+ , Co 2+ , One or more of Ni 2+ .

优选的,所述有机多元酸金属离子配合物为丁二酸镁。Preferably, the organic polybasic acid metal ion complex is magnesium succinate.

优选的,在丁二酸镁催化下引入异戊烯基的反应方程式如下:Preferably, the reaction equation that introduces isopentenyl under the catalysis of magnesium succinate is as follows:

Figure BDA0002222605170000051
Figure BDA0002222605170000051

优选的,所述异戊烯基黄酮类化合物为淫羊藿素或其衍生物;所述淫羊藿素或其衍生物由化合物6通过如下反应方程式获得:Preferably, the isopentenyl flavonoid compound is icariin or a derivative thereof; the icariin or a derivative thereof is obtained from compound 6 by the following reaction equation:

Figure BDA0002222605170000052
Figure BDA0002222605170000052

其中,P1、P2均选自烷基、烷氧基烷基、烷胺基烷基、硅醚基、硫醚基、环烷基、环杂烷基、烯基、炔基、芳基、芳杂环基、酰基、磺酸基、亚磺酸基、磷酸基中的一种或几种;P3选自H、烷基、烷氧烷基、烷胺基烷基、硅醚基、硫醚基、环烷基、环杂烷基、烯基、炔基、芳基、芳杂基、酰基、磺酸基、亚磺酸基、磷酸基中的一种或几种;R3选自H、烷基、烷氧烷基、烷胺基烷基、环烷基、环杂烷基、烯基、炔基、芳基、芳杂环基、氰基、卤素、酰基、酰胺基、酯基、磺酸基、磺酸胺基、磺酸酯基、亚磺酸基、亚磺酸胺基、亚磺酸酯基、氨基、胺基、硫醚基、硝基、磷酸胺基、磷酸酯基中的任意一种;R1′、R2′、R3′、R4′选自H、烷基、烷氧烷基、烷胺基烷基、环烷基、环杂烷基、烯基、炔基、芳基、芳杂环基、氰基、卤素、酰基、酰胺基、酯基、磺酸基、磺酸胺基、磺酸酯基、亚磺酸基、亚磺酸胺基、亚磺酸酯基、磷酸胺基、磷酸酯基、氨基、胺基、硫醚基、硝基中的任意一种。Wherein, P 1 and P 2 are both selected from alkyl, alkoxyalkyl, alkylaminoalkyl, silyl ether, thioether, cycloalkyl, cycloheteroalkyl, alkenyl, alkynyl, aryl , one or more of aromatic heterocyclic group, acyl group, sulfonic acid group, sulfinic acid group and phosphoric acid group; P 3 is selected from H, alkyl group, alkoxyalkyl group, alkylamino alkyl group, silyl ether group , one or more of thioether group, cycloalkyl group, cycloheteroalkyl group, alkenyl group, alkynyl group, aryl group, aromatic hetero group, acyl group, sulfonic acid group, sulfinic acid group and phosphoric acid group; R 3 Selected from H, alkyl, alkoxyalkyl, alkylaminoalkyl, cycloalkyl, cycloheteroalkyl, alkenyl, alkynyl, aryl, aromatic heterocyclyl, cyano, halogen, acyl, amido , ester group, sulfonic acid group, sulfonic acid amine group, sulfonic acid ester group, sulfinic acid group, sulfinic acid amine group, sulfinic acid ester group, amino group, amine group, thioether group, nitro group, phosphoric acid amine group , any one of phosphate groups; R 1 ', R 2 ', R 3 ', R 4 ' are selected from H, alkyl, alkoxyalkyl, alkylaminoalkyl, cycloalkyl, cycloheteroalkane group, alkenyl group, alkynyl group, aryl group, aromatic heterocyclic group, cyano group, halogen, acyl group, amide group, ester group, sulfonic acid group, sulfonic acid amino group, sulfonic acid ester group, sulfinic acid group, sulfinic acid group Any one of acid amine group, sulfinate group, phosphoric acid amine group, phosphoric acid ester group, amino group, amine group, thioether group and nitro group.

优选的,所述化合物6由化合物4、5通过如下反应方程式获得:Preferably, the compound 6 is obtained from the compounds 4 and 5 by the following reaction equation:

Figure BDA0002222605170000061
Figure BDA0002222605170000061

优选的,所述化合物4由化合物3通过如下反应方程式获得:Preferably, the compound 4 is obtained from the compound 3 by the following reaction equation:

Figure BDA0002222605170000062
Figure BDA0002222605170000062

优选的,所述淫羊藿素的全合成方法为:Preferably, the total synthesis method of described icariin is:

Figure BDA0002222605170000063
Figure BDA0002222605170000063

相应的,一种利用所述异戊烯基黄酮类化合物的全合成方法合成的化合物,结构式为:Correspondingly, a compound synthesized by the total synthesis method of described isopentenyl flavonoids, the structural formula is:

Figure BDA0002222605170000064
Figure BDA0002222605170000064

优选的,所述化合物的合成方法为:Preferably, the synthetic method of the compound is:

Figure BDA0002222605170000071
Figure BDA0002222605170000071

本发明具有以下有益效果:本方法采用先引入异戊烯基再构建黄酮骨架的策略,有效地解决了现有方法在引入异戊烯基的反应中各底物因溶解性差而不兼容的问题,与现有方法相比,合成策略的改变避免了保护基的频繁引入和脱除的步骤,极大地简化了反应路线。另外,本方法引入异戊烯基时使用丁二酸镁做催化剂,反应体现出了较好的区域选择性;构建黄酮骨架时反应介质为水或醇水混合溶剂,氧化剂为大气或氧气,绿色环保,总体收率良好,适合大规模的工业生产,解决了该类化合物现有合成方法步骤冗长、收率较低的问题。The invention has the following beneficial effects: the method adopts the strategy of first introducing the isopentenyl group and then constructing the flavonoid skeleton, which effectively solves the problem that each substrate is incompatible due to poor solubility in the reaction of introducing the isopentenyl group in the existing method , compared with existing methods, the change of synthesis strategy avoids the steps of frequent introduction and removal of protecting groups, which greatly simplifies the reaction route. In addition, magnesium succinate is used as a catalyst when the isopentenyl group is introduced in this method, and the reaction shows good regioselectivity; when the flavonoid skeleton is constructed, the reaction medium is water or a mixed solvent of alcohol and water, the oxidant is the atmosphere or oxygen, and the green It is environmentally friendly, has good overall yield, is suitable for large-scale industrial production, and solves the problems of lengthy steps and low yield in the existing synthesis method of such compounds.

具体实施方式Detailed ways

本发明提供了一种全合成淫羊藿素及其衍生物的方法。下述方法中涉及到的各化合物的化学结构式如表1所示。The invention provides a method for fully synthesizing icariin and derivatives thereof. The chemical structures of the compounds involved in the following methods are shown in Table 1.

表1各化合物对应的结构式The corresponding structural formula of each compound in Table 1

Figure BDA0002222605170000072
Figure BDA0002222605170000072

Figure BDA0002222605170000081
Figure BDA0002222605170000081

具体合成反应式通式如下:The specific synthesis reaction formula is as follows:

Figure BDA0002222605170000082
Figure BDA0002222605170000082

具体包括如下步骤:Specifically include the following steps:

1、将化合物1与化合物2在有机多元酸金属离子配合物的催化下反应,生成化合物3。1. Compound 1 is reacted with compound 2 under the catalysis of an organic polybasic acid metal ion complex to generate compound 3.

其中,所述化合物1的R3选自H、烷基、烷氧烷基、烷胺基烷基、环烷基、环杂烷基、烯基、炔基、芳基、芳杂环基、氰基、卤素、酰基、酰胺基、酯基、磺酸基、磺酸胺基、磺酸酯基、亚磺酸基、亚磺酸胺基、亚磺酸酯基、氨基、胺基、硫醚基、硝基、磷酸胺基、磷酸酯基中的任意一种,优选的,R3选自H。化合物1可以直接市购获得,也可以以间苯三酚为原料,乙腈为乙酰基供体,在路易斯酸和卤化氢气体的作用下合成得到。所述的路易斯酸选自锌盐、铁盐、铜盐、镁盐、铝盐中的一种或几种,优选的方案为,所述的路易斯酸选自氯化锌。Wherein, R 3 of the compound 1 is selected from H, alkyl, alkoxyalkyl, alkylaminoalkyl, cycloalkyl, cycloheteroalkyl, alkenyl, alkynyl, aryl, aromatic heterocyclyl, cyano group, halogen, acyl group, amide group, ester group, sulfonic acid group, sulfonic acid amine group, sulfonic acid ester group, sulfinic acid group, sulfinic acid amine group, sulfinic acid ester group, amino group, amine group, sulfur Any one of ether group, nitro group, phosphoric acid amine group and phosphoric acid ester group, preferably, R 3 is selected from H. Compound 1 can be obtained directly from the market, or can be synthesized by using phloroglucinol as a raw material and acetonitrile as an acetyl donor under the action of Lewis acid and hydrogen halide gas. The Lewis acid is selected from one or more of zinc salts, iron salts, copper salts, magnesium salts, and aluminum salts. A preferred solution is that the Lewis acid is selected from zinc chloride.

所述化合物2的X选自氯、溴、碘、甲磺酸酯基和对甲苯磺酸酯基、三氟甲磺酸酯基中的一种或几种;优选的,X选自异戊烯基氯、异戊烯基溴、异戊烯基碘中的一种或几种。X of the compound 2 is selected from one or more of chlorine, bromine, iodine, mesylate, p-toluenesulfonate, and trifluoromethanesulfonate; preferably, X is selected from isopentane One or more of alkenyl chloride, isopentenyl bromide and isopentenyl iodide.

所述的有机多元酸金属离子配合物的制备方法为:将金属氢氧化物与有机多元酸加入水中反应得到。其中,所述有机多元酸选C2~C18的二元脂肪羧酸、C3~C18的三元脂肪羧酸、C4~C18的四元脂肪羧酸、C8~C18的多元芳香羧酸。优选的,所述有机多元酸选自丙二酸、丁二酸、戊二酸中的一种或几种。The preparation method of the organic polybasic acid metal ion complex is as follows: adding metal hydroxide and organic polybasic acid into water to react. Wherein, the organic polybasic acid is selected from C2 - C18 dibasic aliphatic carboxylic acid, C3 - C18 tribasic aliphatic carboxylic acid, C4 - C18 tetrabasic aliphatic carboxylic acid, C8- C18 aliphatic carboxylic acid polyaromatic carboxylic acid. Preferably, the organic polybasic acid is selected from one or more of malonic acid, succinic acid and glutaric acid.

所述金属离子选自Mg2+、Al3+、Zn2+、Cu2+、Ba2+、Fe3+、Co2+、Ni2+中的一种或几种。优选的,所述金属离子选自Mg2+、Al3+、Zn2中的一种或几种。The metal ions are selected from one or more of Mg 2+ , Al 3+ , Zn 2+ , Cu 2+ , Ba 2+ , Fe 3+ , Co 2+ , and Ni 2+ . Preferably, the metal ions are selected from one or more of Mg 2+ , Al 3+ , and Zn 2 .

2、将所述化合物3进行4、6位酚羟基的选择性保护,生成化合物4。将所述化合物4与化合物5进行一锅法反应,生成化合物6。2. The compound 3 is selectively protected at the 4- and 6-position phenolic hydroxyl groups to generate compound 4. The compound 4 is reacted with compound 5 in a one-pot reaction to generate compound 6.

所述化合物4的酚羟基的保护剂P1、P2均选自烷基、烷氧基烷基、烷胺基烷基、硅醚基、硫醚基、环烷基、环杂烷基、烯基、炔基、芳基、芳杂环基、酰基、磺酸基、亚磺酸基、磷酸基中的一种或几种。优选的,P1、P2选自甲氧基甲基、乙氧基乙基、2-甲氧基乙氧基甲基、四氢吡喃、苄基、对甲氧基苄基、乙酰基、三氟乙酰基、苯甲酰基中的一种或几种。The protective agents P 1 and P 2 of the phenolic hydroxyl group of the compound 4 are all selected from alkyl, alkoxyalkyl, alkylaminoalkyl, silyl ether, thioether, cycloalkyl, cycloheteroalkyl, One or more of alkenyl group, alkynyl group, aryl group, aromatic heterocyclic group, acyl group, sulfonic acid group, sulfinic acid group and phosphoric acid group. Preferably, P 1 and P 2 are selected from methoxymethyl, ethoxyethyl, 2-methoxyethoxymethyl, tetrahydropyran, benzyl, p-methoxybenzyl, acetyl , one or more of trifluoroacetyl and benzoyl.

所述化合物5中的R1′、R2′、R3′、R4′选自H、烷基、烷氧烷基、烷胺基烷基、环烷基、环杂烷基、烯基、炔基、芳基、芳杂环基、氰基、卤素、酰基、酰胺基、酯基、磺酸基、磺酸胺基、磺酸酯基、亚磺酸基、亚磺酸胺基、亚磺酸酯基、磷酸胺基、磷酸酯基、氨基、胺基、硫醚基、硝基中的任意一种。优选的,R1′、R2′、R3′、R4′选自H;P3选自H、烷基、烷氧烷基、烷胺基烷基、硅醚基、硫醚基、环烷基、环杂烷基、烯基、炔基、芳基、芳杂基、酰基、磺酸基、亚磺酸基、磷酸基中的一种或几种。优选的,P3选自烷基。R 1 ', R 2 ', R 3 ', R 4 ' in the compound 5 are selected from H, alkyl, alkoxyalkyl, alkylaminoalkyl, cycloalkyl, cycloheteroalkyl, alkenyl , alkynyl group, aryl group, aromatic heterocyclic group, cyano group, halogen group, acyl group, amide group, ester group, sulfonic acid group, sulfonic acid amino group, sulfonic acid ester group, sulfinic acid group, sulfinic acid amino group, Any of a sulfinate group, a phosphoric acid amine group, a phosphoric acid ester group, an amino group, an amine group, a thioether group, and a nitro group. Preferably, R 1 ', R 2 ', R 3 ', R 4 ' are selected from H; P 3 is selected from H, alkyl, alkoxyalkyl, alkylaminoalkyl, silyl ether, thioether, One or more of cycloalkyl, cycloheteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, acyl, sulfonic acid, sulfinic, and phosphoric acid groups. Preferably, P 3 is selected from alkyl.

所述化合物6中的P1、P2、R1′、R2′、R3′、R4′、P3与化合物4、5中的相同。P 1 , P 2 , R 1 ′, R 2 ′, R 3 ′, R 4 ′ and P 3 in the compound 6 are the same as those in the compounds 4 and 5.

3、将化合物6进一步保护,反应生成所需的淫羊藿素或其衍生物,即化合物7。应当理解的是,表1中的化合物7为淫羊藿素衍生物的典型代表,在表1中只为示例,并非限定化合物7只能为表1中的结构。3. The compound 6 is further protected, and the desired icariin or its derivative, namely compound 7, is produced by the reaction. It should be understood that Compound 7 in Table 1 is a typical representative of icariin derivatives, and it is only an example in Table 1, and it is not limited that Compound 7 can only have the structure in Table 1.

本步反应中,反应溶剂选自水、醇类、羧酸、醚类、酯类、酮类、氰类、含氯溶剂中的一种或几种。优选的,所述的反应溶剂选择水、醇类中的一种或几种。本步反应时,需要加入脱保护剂,所述脱保护剂选自脱烷基醚类保护剂。优选的,所述脱烷基醚类保护剂选自质子酸或路易斯酸。更优选的,所述脱烷基醚类保护剂选自盐酸、三氟乙酸中的一种或几种。In this step reaction, the reaction solvent is selected from one or more of water, alcohols, carboxylic acids, ethers, esters, ketones, cyanogens, and chlorine-containing solvents. Preferably, the reaction solvent is selected from one or more of water and alcohols. During the reaction in this step, a deprotection agent needs to be added, and the deprotection agent is selected from dealkylated ether protection agents. Preferably, the dealkylated ether protective agent is selected from protonic acid or Lewis acid. More preferably, the dealkylated ether protective agent is selected from one or more of hydrochloric acid and trifluoroacetic acid.

下面以生成淫羊藿素为例,结合实施例对本发明进行进一步阐释。The present invention will be further explained below with reference to the examples of generating icariin.

实施例Example

需要说明的是,本实施例中涉及较多结构复杂的化合物,为方便展示,在阐释时使用“化合物+罗马数字”的形式代表某一化合物,例如:2,4,6-三羟基-3-异戊烯基苯乙酮,即为化合物ⅱ。It should be noted that this example involves more compounds with complex structures. For the convenience of presentation, the form of "compound + Roman numerals" is used to represent a certain compound, for example: 2,4,6-trihydroxy-3 -Prenylacetophenone, which is compound ii.

全合成淫羊藿素的反应方程式如下:The reaction equation for the total synthesis of icariin is as follows:

Figure BDA0002222605170000101
Figure BDA0002222605170000101

各缩写对应的化合物分别为:(1)DMF:N,N-二甲基甲酰胺;(2)MOMCl:氯甲基甲醚;(3)DIPEA:N,N-二异丙基乙胺。The compounds corresponding to each abbreviation are: (1) DMF: N,N-dimethylformamide; (2) MOMCl: chloromethyl methyl ether; (3) DIPEA: N,N-diisopropylethylamine.

全合成淫羊藿素的具体步骤如下:The specific steps for the total synthesis of icariin are as follows:

1、合成丁二酸镁1. Synthesis of magnesium succinate

室温下,将化合物氢氧化镁(1.0g,17.2mmol)、去离子水(20mL)加入反应瓶中,升温至100℃搅拌30min,再向上述反应液中加入5mL丁二酸水溶液(3.4mol/L),加毕,继续100℃搅拌反应1h,至固体完全溶解,将反应液冷至室温,浓缩溶剂至干得白色固体,即为丁二酸镁(2.63g),收率99.5%。反应式如下所示:At room temperature, the compound magnesium hydroxide (1.0 g, 17.2 mmol) and deionized water (20 mL) were added to the reaction flask, the temperature was raised to 100 ° C and stirred for 30 min, and 5 mL of succinic acid aqueous solution (3.4 mol/mL) was added to the above reaction solution. L), after adding, continue stirring at 100 °C for 1 h until the solid is completely dissolved, cool the reaction solution to room temperature, and concentrate the solvent to dryness to obtain a white solid, which is magnesium succinate (2.63 g), with a yield of 99.5%. The reaction formula is as follows:

Figure BDA0002222605170000111
Figure BDA0002222605170000111

2、合成2,4,6-三羟基-3-异戊烯基苯乙酮(ⅱ)2. Synthesis of 2,4,6-trihydroxy-3-isopentenylacetophenone (II)

本步的反应方程式如下:The reaction equation for this step is as follows:

在室温环境下,将化合物2,4,6-三羟基苯乙酮一水合物(1.0g,5.37mmol)溶解于5mL干燥DMF中,随后依次加入丁二酸镁(0.75g,5.37mmol)、异戊烯基氯(0.56g,5.37mmol)、碘化钾(90mg,0.54mmol)。加毕,在氩气保护下,升温至40℃搅拌反应16h,反应至TLC监测原料消失,将反应液冷至室温,再倒入冰水中淬灭反应,使用3×10mL乙酸乙酯萃取,合并有机相并依次经饱和氯化钠溶液洗涤、无水硫酸钠干燥后,减压浓缩有机相至干燥,再经硅胶柱层析[V(石油醚):V(乙酸乙酯)=6:1]纯化,得白色固体的化合物ⅱ,质量为0.82g,收率为65%。核磁共振氢谱和碳谱数据如下:At room temperature, compound 2,4,6-trihydroxyacetophenone monohydrate (1.0 g, 5.37 mmol) was dissolved in 5 mL of dry DMF, followed by adding magnesium succinate (0.75 g, 5.37 mmol), Prenyl chloride (0.56 g, 5.37 mmol), potassium iodide (90 mg, 0.54 mmol). After the addition was completed, under the protection of argon, the temperature was raised to 40 °C and the reaction was stirred for 16 h. The reaction was performed until the TLC monitored the disappearance of the raw materials. The reaction solution was cooled to room temperature, and then poured into ice water to quench the reaction, extracted with 3×10 mL of ethyl acetate, and combined. The organic phase was successively washed with saturated sodium chloride solution and dried over anhydrous sodium sulfate. The organic phase was concentrated under reduced pressure to dryness, and then subjected to silica gel column chromatography [V(petroleum ether):V(ethyl acetate)=6:1 ] was purified to obtain compound II as a white solid with a mass of 0.82 g and a yield of 65%. The H NMR and C NMR data are as follows:

1H NMR(400MHz,DMSO-d6)δ14.01(s,1H),10.52(s,1H),10.29(s,1H),6.00(s,1H),5.23–5.03(m,1H),3.08(d,J=7.1Hz,2H),2.56(s,3H),1.69(s,3H),1.61(s,3H).13C NMR(101MHz,DMSO-d6)δ202.94,163.63,162.83,160.62,130.01,123.81,106.14,104.31,94.45,32.89,25.95,21.35,18.09.m/z=237.1[M+H]+. 1 H NMR (400MHz, DMSO-d 6 )δ14.01(s,1H), 10.52(s,1H), 10.29(s,1H), 6.00(s,1H), 5.23-5.03(m,1H), 3.08(d, J=7.1Hz, 2H), 2.56(s, 3H), 1.69(s, 3H), 1.61(s, 3H). 13 C NMR(101MHz, DMSO-d 6 )δ202.94,163.63,162.83, 160.62, 130.01, 123.81, 106.14, 104.31, 94.45, 32.89, 25.95, 21.35, 18.09.m/z=237.1[M+H] + .

3、合成2-羟基-3-异戊烯基-4,6-双(甲氧基甲氧基)–苯乙酮(ⅲ)3. Synthesis of 2-hydroxy-3-prenyl-4,6-bis(methoxymethoxy)-acetophenone (ⅲ)

本步的反应方程式如下:The reaction equation for this step is as follows:

Figure BDA0002222605170000121
Figure BDA0002222605170000121

在冰水浴下,将化合物ⅱ(0.5g,2.11mmol)加入5mL干燥丙酮中,滴加N,N-二异丙基乙胺(0.82g,6.33mmol)。加毕,搅拌反应10min,然后加入氯甲基甲醚(0.51g,6.33mmol),加毕,在氩气保护下,升温至60℃,回流反应2h,反应至TLC监测原料消失。随后将反应液冷至室温,倒入冰水中淬灭反应,使用3×10mL乙酸乙酯萃取。合并有机相并一次经饱和氯化钠溶液洗涤、无水硫酸钠干燥后,减压浓缩有机相至干燥,再经硅胶柱层析[V(石油醚):V(乙酸乙酯)=10:1]纯化得黄色油状的化合物ⅲ。质量为0.64g,收率为93%。核磁共振氢谱和碳谱数据如下:Under an ice-water bath, compound ii (0.5 g, 2.11 mmol) was added to 5 mL of dry acetone, and N,N-diisopropylethylamine (0.82 g, 6.33 mmol) was added dropwise. After the addition was completed, the reaction was stirred for 10 min, and then chloromethyl methyl ether (0.51 g, 6.33 mmol) was added. After the addition was completed, the temperature was raised to 60° C. under the protection of argon, and the reaction was refluxed for 2 h. The reaction was performed until TLC monitored the disappearance of the raw materials. The reaction solution was then cooled to room temperature, poured into ice water to quench the reaction, and extracted with 3×10 mL of ethyl acetate. The organic phases were combined, washed once with saturated sodium chloride solution, dried over anhydrous sodium sulfate, concentrated under reduced pressure to dryness, and then subjected to silica gel column chromatography [V(petroleum ether):V(ethyl acetate)=10: 1] Purified compound iii as yellow oil. The mass was 0.64 g, and the yield was 93%. The H NMR and C NMR data are as follows:

1H NMR(400MHz,DMSO-d6)δ13.87(s,1H),6.37(s,1H),5.32(s,2H),5.30(s,2H),5.11(t,J=7.0Hz,1H),3.45(s,3H),3.40(s,3H),3.19(d,J=7.0Hz,3H),2.64(s,3H),1.72(s,3H),1.61(s,3H).13C NMR(101MHz,DMSO-d6)δ204.08,162.85,160.88,158.99,130.95,122.90,110.47,106.62,94.97,94.13,91.97,56.96,56.49,33.44,25.94,21.54,18.07.m/z=325.2[M+H]+. 1 H NMR (400MHz, DMSO-d 6 )δ13.87(s, 1H), 6.37(s, 1H), 5.32(s, 2H), 5.30(s, 2H), 5.11(t, J=7.0Hz, 1H), 3.45(s, 3H), 3.40(s, 3H), 3.19(d, J=7.0Hz, 3H), 2.64(s, 3H), 1.72(s, 3H), 1.61(s, 3H). 13 C NMR (101MHz, DMSO-d 6 )δ204.08,162.85,160.88,158.99,130.95,122.90,110.47,106.62,94.97,94.13,91.97,56.96,56.49,33.44,25.94,21.354,28=. [M+H] + .

4、合成5,7-二甲氧基甲基-淫羊藿素(ⅳ)4. Synthesis of 5,7-dimethoxymethyl-icariin (IV)

本步的反应方程式如下:The reaction equation for this step is as follows:

Figure BDA0002222605170000131
Figure BDA0002222605170000131

在室温环境下,将化合物ⅲ(0.6g,1.85mmol)、4-甲氧基苯甲醛(0.27g,1.95mmol)、MeOH(3mL)和H2O(9mL)加入反应瓶中,然后加入吡咯烷(1.5mL,18.5mmol)。加毕,升至50℃,敞口搅拌反应16h,反应至TLC监测原料消失,将反应液冷至室温,倒入冰水中淬灭反应。用1N盐酸调pH=4.0,使用3×10mL二氯甲烷萃取,合并有机相并依次经饱和氯化钠溶液洗涤、无水硫酸钠干燥后,减压浓缩有机相至干燥,再经硅胶柱层析[V(石油醚):V(丙酮)=5:1]纯化,得黄色油状的化合物ⅳ,质量为0.48g,收率为57%。核磁共振氢谱和碳谱数据如下:At room temperature, compound iii (0.6 g, 1.85 mmol), 4-methoxybenzaldehyde (0.27 g, 1.95 mmol), MeOH (3 mL) and H 2 O (9 mL) were added to a reaction flask, followed by pyrrole alkane (1.5 mL, 18.5 mmol). After the addition was completed, the temperature was raised to 50°C, and the reaction was stirred openly for 16 h. The reaction was performed until the TLC monitored the disappearance of the raw materials. The reaction solution was cooled to room temperature and poured into ice water to quench the reaction. Adjust pH=4.0 with 1N hydrochloric acid, extract with 3×10 mL of dichloromethane, combine the organic phases, wash with saturated sodium chloride solution in turn, dry with anhydrous sodium sulfate, concentrate the organic phase under reduced pressure to dryness, and then pass through a silica gel column layer. Analysis [V (petroleum ether): V (acetone) = 5: 1] was purified to obtain yellow oily compound IV, the mass was 0.48 g, and the yield was 57%. The H NMR and C NMR data are as follows:

1H NMR(400MHz,CDCl3)δ8.22(d,J=9.0Hz,2H),7.06(d,J=8.9Hz,2H),6.95(s,1H),5.39(s,2H),5.32(s,2H),5.26(dd,J=13.2,6.4Hz,1H),3.92(s,3H),3.65(d,J=6.7Hz,2H),3.60(s,3H),3.53(s,3H),1.86(s,3H),1.71(s,3H).13C NMR(101MHz,CDCl3)δ172.31,161.73,158.64,155.92,147.51,145.66,137.22,137.14,132.28,129.05,122.05,114.07,112.30,111.52,98.69,95.76,94.45,56.65,56.47,55.41,25.77,22.24,18.05.m/z=457.2[M+H]+.。 1 H NMR (400 MHz, CDCl 3 ) δ 8.22 (d, J=9.0 Hz, 2H), 7.06 (d, J=8.9 Hz, 2H), 6.95 (s, 1H), 5.39 (s, 2H), 5.32 (s, 2H), 5.26(dd, J=13.2, 6.4Hz, 1H), 3.92(s, 3H), 3.65(d, J=6.7Hz, 2H), 3.60(s, 3H), 3.53(s, 3H), 1.86(s, 3H), 1.71(s, 3H). 13 C NMR (101MHz, CDCl 3 )δ172.31, 161.73, 158.64, 155.92, 147.51, 145.66, 137.22, 137.14, 132.28, 129.05, 122.05, 114. 112.30, 111.52, 98.69, 95.76, 94.45, 56.65, 56.47, 55.41, 25.77, 22.24, 18.05.m/z=457.2[M+H] + ..

5、合成淫羊藿素5. Synthetic icariin

本步的反应方程式如下:The reaction equation for this step is as follows:

Figure BDA0002222605170000132
Figure BDA0002222605170000132

在室温环境下,将化合物ⅳ(0.6g,1.32mmol)、甲醇(15mL)和盐酸(3mol/L,5mL)加入反应瓶中,在氩气保护下,升温至65℃,回流反应1h,反应至TLC监测原料消失,将反应液冷至室温,减压浓缩除去甲醇,粗产品经过滤水洗后,烘干得黄色固体化合物7,质量为0.46g,收率为95%。所述化合物7的核磁共振氢谱和碳谱数据如下:At room temperature, compound IV (0.6 g, 1.32 mmol), methanol (15 mL) and hydrochloric acid (3 mol/L, 5 mL) were added to the reaction flask. After TLC monitoring of the disappearance of the raw materials, the reaction solution was cooled to room temperature, concentrated under reduced pressure to remove methanol, the crude product was filtered and washed with water, and dried to obtain a yellow solid compound 7 with a mass of 0.46 g and a yield of 95%. The H NMR and C NMR data of the compound 7 are as follows:

1H NMR(400MHz,DMSO-d6)δ12.39(s,1H),10.77(s,1H),9.51(s,1H),8.14(d,J=8.8Hz,2H),7.14(d,J=8.8Hz,2H),6.31(s,1H),5.19(t,J=6.2Hz,1H),3.86(s,3H),3.44(d,J=7.0Hz,2H),1.76(s,2H),1.64(s,3H).m/z=369.1[M+H]+. 1 H NMR (400MHz, DMSO-d 6 ) δ 12.39(s, 1H), 10.77(s, 1H), 9.51(s, 1H), 8.14(d, J=8.8Hz, 2H), 7.14(d, J=8.8Hz, 2H), 6.31(s, 1H), 5.19(t, J=6.2Hz, 1H), 3.86(s, 3H), 3.44(d, J=7.0Hz, 2H), 1.76(s, 2H),1.64(s,3H).m/z=369.1[M+H] + .

上述核磁共振氢谱和碳谱数据与淫羊藿素的数据相符,至此,即反应生成了所需的淫羊藿素。The above-mentioned H NMR and C NMR data are consistent with the data of icariin, so far, the desired icariin is produced by the reaction.

Claims (10)

1. A full synthesis method of isopentene flavonoid compounds is characterized in that: isopentene group is introduced under the catalytic action of organic polyacid metal ion complex, and then a flavone skeleton is constructed.
2. The total synthesis method of isopentenyl flavonoid compound according to claim 1, characterized in that: in the organic polybasic acid metal ion complex, the organic polybasic acid is one or more of C2-C18 dibasic aliphatic carboxylic acid, C3-C18 tribasic aliphatic carboxylic acid, C4-C18 tetrabasic aliphatic carboxylic acid and C8-C18 polybasic aromatic carboxylic acid; the metal ion is selected from Mg2+、Al3+、Zn2+、Cu2+、Ba2+、Fe3+、Co2+、Ni2+One or more of (a).
3. The total synthesis method of isopentenyl flavonoids according to claim 1, which is characterized in that: the organic polyacid metal ion complex is magnesium succinate.
4. The total synthesis method of isopentenyl flavonoids according to claim 3, which is characterized in that: the reaction equation for introducing isopentene under catalysis of magnesium succinate is as follows:
Figure FDA0002222605160000011
the R is3Selected from H, alkyl, alkoxyalkyl, alkylaminoalkyl, cycloalkyl, cycloheteroalkyl, alkenyl, alkynyl, aryl, arylheterocyclyl, cyano, halogen, acyl, amido, ester, sulfonic acid amido, sulfonic acid, and the likeAny one of an ester group, a sulfinic acid amine group, a sulfinic acid ester group, an amino group, an amine group, a thioether group, a nitro group, an amine phosphate group and a phosphate ester group.
5. The total synthesis method of isopentenyl flavonoids according to any one of claims 1 to 4, wherein the total synthesis method comprises the following steps: the isopentene flavonoid compound is icaritin or a derivative thereof; the icaritin or the derivative thereof is obtained from the compound 6 through the following reaction equation:
Figure FDA0002222605160000012
wherein, P1、P2All selected from one or more of alkyl, alkoxyalkyl, alkylamino alkyl, silicon ether, thioether, cycloalkyl, cycloheteroalkyl, alkenyl, alkynyl, aryl, aromatic heterocyclic group, acyl, sulfonic group, sulfinic group and phosphoric group; p3One or more selected from H, alkyl, alkoxy alkyl, alkyl amino alkyl, silicon ether, thioether group, naphthenic group, cycloheteroalkyl, alkenyl, alkynyl, aryl, heteroaryl, acyl, sulfonic group, sulfinic group and phosphoric group; the R is3Any one selected from H, alkyl, alkoxyalkyl, alkylaminoalkyl, cycloalkyl, cycloheteroalkyl, alkenyl, alkynyl, aryl, aromatic heterocyclic group, cyano, halogen, acyl, amide group, ester group, sulfonic acid amino group, sulfonic ester group, sulfinic acid amino group, sulfinic ester group, amino group, thioether group, nitro group, phosphoric acid amino group and phosphoric ester group; r1′、R2′、R3′、R4' is any one selected from the group consisting of H, alkyl, alkoxyalkyl, alkylaminoalkyl, cycloalkyl, cycloheteroalkyl, alkenyl, alkynyl, aryl, arylheterocyclyl, cyano, halogen, acyl, amide, ester, sulfonic acid amine, sulfonic acid ester, sulfinic acid amine, sulfinic acid ester, phosphoric acid amine, phosphoric acid ester, amino, amine, thioether, and nitro.
6. The total synthesis method of isopentenyl flavonoids according to claim 5, which is characterized in that: the compound 6 is obtained from the compounds 4 and 5 through the following reaction equation:
Figure FDA0002222605160000021
7. the total synthesis method of isopentenyl flavonoids according to claim 6, which comprises the following steps: the compound 4 is obtained from the compound 3 by the following reaction equation:
Figure FDA0002222605160000022
8. the total synthesis method of isopentenyl flavonoids according to any one of claims 5 to 7, which comprises the following steps: the total synthesis method of the icaritin comprises the following steps:
Figure FDA0002222605160000031
9. a compound synthesized by the total synthesis method of the isopentenyl flavonoid compound disclosed by claim 8, which is characterized in that: the structural formula is as follows:
Figure FDA0002222605160000032
10. the compound synthesized by the total synthesis method of isopentenyl flavonoid compound according to claim 9, wherein: the synthesis method of the compound comprises the following steps:
Figure FDA0002222605160000033
CN201910939978.7A 2019-09-30 2019-09-30 A simple and efficient total synthesis method of icariin and its derivatives Pending CN110684003A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910939978.7A CN110684003A (en) 2019-09-30 2019-09-30 A simple and efficient total synthesis method of icariin and its derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910939978.7A CN110684003A (en) 2019-09-30 2019-09-30 A simple and efficient total synthesis method of icariin and its derivatives

Publications (1)

Publication Number Publication Date
CN110684003A true CN110684003A (en) 2020-01-14

Family

ID=69111243

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910939978.7A Pending CN110684003A (en) 2019-09-30 2019-09-30 A simple and efficient total synthesis method of icariin and its derivatives

Country Status (1)

Country Link
CN (1) CN110684003A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112521269A (en) * 2020-12-23 2021-03-19 郑州瑞普生物工程有限公司 Preparation method of magnesium succinate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101205223A (en) * 2006-12-18 2008-06-25 李毅林 Total synthesis method of natural product barrenwort glycosides compounds
WO2016183905A1 (en) * 2015-05-20 2016-11-24 佛山市金骏康健康科技有限公司 Icarisid compound, preparation method therefor, and application thereof
CN107163014A (en) * 2016-07-15 2017-09-15 北京盛诺基医药科技有限公司 A kind of synthetic method of icariine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101205223A (en) * 2006-12-18 2008-06-25 李毅林 Total synthesis method of natural product barrenwort glycosides compounds
WO2016183905A1 (en) * 2015-05-20 2016-11-24 佛山市金骏康健康科技有限公司 Icarisid compound, preparation method therefor, and application thereof
CN107163014A (en) * 2016-07-15 2017-09-15 北京盛诺基医药科技有限公司 A kind of synthetic method of icariine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
牟关敏等: "淫羊藿素的合成", 《有机化学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112521269A (en) * 2020-12-23 2021-03-19 郑州瑞普生物工程有限公司 Preparation method of magnesium succinate
CN112521269B (en) * 2020-12-23 2023-12-22 郑州瑞普生物工程有限公司 Preparation method of magnesium succinate

Similar Documents

Publication Publication Date Title
CN102653533B (en) Total synthesis method of mangostin
CN102746360B (en) Synthesis and application of four new conjugates of camptothecin-steroid
TW201309662A (en) A novel synthesis process of polyphenols
EP2840088B1 (en) Method for preparing 5,6,4'-trihydroxyflavone-7-0-d-glucuronic acid
CN115991688A (en) A kind of heterocycle-containing orange ketone derivative and its application
CN110684003A (en) A simple and efficient total synthesis method of icariin and its derivatives
CN110003159A (en) Synthesize the new method of catechin
CN103304466A (en) Synthetic method of 3-alkyl-substituted indole compound
CN103664782B (en) ICD derivant and its preparation method and application
EP2868657A1 (en) Method for preparing high purity scutellarin aglycone
CN104610212B (en) Icaritin derivatives as well as preparation method and application thereof
CN101250176A (en) A kind of flavonol sulfonate derivative and its synthesis method
CN103864877B (en) A kind of preparation method of Abiraterone acetate
CN113999164B (en) Preparation method of halofuginone intermediate trans-N-benzyloxycarbonyl- (3-hydroxy-2-piperidinyl) -2-propanone
CN112062669A (en) Process for preparing aromatic compounds
KR20010028782A (en) Preparative method of 7-carboxymethyloxy-3',4',5-trimethoxyflavone
CN108484617B (en) Novel benzofuran azanaphthalene dione derivative and preparation method thereof
CN108484623B (en) Camptothecin derivatives and preparation method and application thereof
CN111484538B (en) A kind of preparation method of homopsyllogenin
CN113896616A (en) A kind of preparation method of cannabidiol
Wang et al. A practical synthesis of the flavone, scutellarein
JP7550982B2 (en) Methods for the preparation of cannabis flavonoids
CN116120238B (en) Preparation method of imidazole derivative
CN115073485B (en) 3-aryl-7, 8-pyranocoumarin derivative, and preparation method and application thereof
CN109438543A (en) A kind of preparation method of high-purity fluticasone furoate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
AD01 Patent right deemed abandoned

Effective date of abandoning: 20230728